What Is Pulmonary Fibrosis? Symptoms, Causes, and Treatment - Gwinnett Pulmonary Sleep
770.995.0630

What Is Pulmonary Fibrosis? Symptoms, Causes, and Treatment by Gwinnett Pulmonary

Pulmonary fibrosis affects how we breathe and live each day. It happens when lung tissue becomes thick and scarred, making it harder for oxygen to move into the bloodstream.

Pulmonary fibrosis is a chronic lung disease that causes scarring in the lungs, leading to shortness of breath, dry cough, and fatigue. Understanding what causes it and how to manage it can make a big difference in staying active and maintaining quality of life.

We often think of breathing as something that just happens, but when the lungs lose flexibility, even simple tasks can feel exhausting. Pulmonary fibrosis can develop from long-term exposure to certain chemicals, autoimmune diseases, or unknown causes.

Some people experience slow changes over the years, while others notice symptoms progress faster.

Key Takeaways

  • Pulmonary fibrosis causes lung scarring that makes breathing difficult.
  • Early diagnosis and treatment can slow disease progression.
  • Ongoing care and lifestyle changes help maintain lung function and comfort.

Understanding Pulmonary Fibrosis

Pulmonary fibrosis causes scarring and stiffness in the lungs, making it harder for us to breathe and for oxygen to move into the bloodstream. It can develop from known causes such as autoimmune diseases or environmental exposures, or it can occur without a known reason, as in idiopathic pulmonary fibrosis (IPF).

Definition and Overview

Pulmonary fibrosis is a chronic lung disease that leads to the thickening and scarring of lung tissue. The word pulmonary means lung, and fibrosis means scar formation.

This scarring damages the structure of the lungs and limits how well they can expand during breathing. As the scarring worsens, the lungs lose their flexibility.

This makes it harder for air to move in and out and for oxygen to pass into the blood. Over time, this can cause persistent shortness of breath, a dry cough, and fatigue.

Pulmonary fibrosis belongs to a broader group of disorders called interstitial lung diseases (ILDs), which involve inflammation or scarring in the tissue around the air sacs (alveoli). The condition can progress slowly or quickly, depending on its type and cause.

How Pulmonary Fibrosis Affects the Lungs

In healthy lungs, the alveoli—tiny air sacs—transfer oxygen into the bloodstream and remove carbon dioxide. In pulmonary fibrosis, the tissue around these alveoli becomes thick and stiff.

This scarring blocks oxygen movement and reduces lung function. As the lungs stiffen, breathing becomes more difficult.

Even simple activities, like walking or climbing stairs, can cause shortness of breath. Low oxygen levels may also lead to fatigue and dizziness.

The damage from fibrosis is usually permanent. In advanced cases, patients may need supplemental oxygen or even a lung transplant.

Types of Pulmonary Fibrosis

Pulmonary fibrosis includes several types, depending on the cause:

Type Description
Idiopathic Pulmonary Fibrosis (IPF) The most common form with no known cause. It often affects older adults.
Secondary Pulmonary Fibrosis Linked to other conditions such as rheumatoid arthritis, scleroderma, or long-term exposure to dusts or chemicals.
Familial Pulmonary Fibrosis Runs in families and may involve genetic factors.

Each type progresses differently. Some remain stable for years, while others worsen quickly.

Identifying the correct type helps guide treatment and predict outcomes.

Who Is at Risk

Several factors can increase our chances of developing pulmonary fibrosis. Age is one of the most significant factors—most cases occur in people over 50.

Men are affected slightly more often than women. Environmental exposures such as silica dust, asbestos, or metal particles can contribute to lung damage.

Long-term use of certain medications and prior radiation therapy to the chest can also raise the risk. People with autoimmune diseases, like rheumatoid arthritis or lupus, face a higher risk as well.

In some families, a genetic link causes familial pulmonary fibrosis, affecting multiple relatives across generations. Lifestyle factors such as smoking and chronic lung irritation can further increase the likelihood of developing this condition.

Pulmonary Fibrosis Symptoms

Pulmonary fibrosis causes scarring in the lungs that makes it difficult for us to breathe and get enough oxygen. The symptoms often start mild but tend to worsen as the disease progresses, affecting how we move, work, and perform daily activities.

Common Signs and Early Symptoms

Early symptoms often include shortness of breath during physical activity and a dry, persistent cough that doesn’t improve with usual treatments. These signs develop gradually and may be mistaken for aging or a mild respiratory infection.

We may also feel fatigue, weakness, or mild chest discomfort. Some people notice unexplained weight loss or loss of appetite as the body works harder to get oxygen.

A few individuals develop clubbing, where the fingertips widen and the nails curve downward. This change happens because of long-term low oxygen levels in the blood.

Progression and Severity of Symptoms

As lung scarring increases, breathing becomes more difficult even at rest. Shortness of breath may occur while talking, showering, or eating.

The dry cough can become constant and tiring, often disrupting sleep. Fatigue grows worse as oxygen levels drop, and we may feel breathless after minimal effort.

Some people experience chest tightness or pain due to strained breathing muscles. Low oxygen saturation can lead to bluish lips or fingertips, a sign that the body is not getting enough oxygen.

Over time, these symptoms limit activity and reduce quality of life. The rate of progression varies, but monitoring changes in breathing and endurance helps track disease severity.

Complications of Pulmonary Fibrosis

Pulmonary fibrosis can lead to several serious complications. One is respiratory failure, which happens when the lungs can no longer supply enough oxygen to the body.

Another is pulmonary hypertension, a type of high blood pressure in the lungs that can strain the heart and cause heart failure. Some patients experience acute exacerbations, or sudden worsening of symptoms, often triggered by infection or unknown causes.

These episodes may require hospitalization and oxygen support. Less common complications include a collapsed lung (pneumothorax), which causes sharp chest pain and sudden shortness of breath.

These events can be life-threatening and need immediate medical care.

When to Seek Medical Attention

We should contact a healthcare provider if we have persistent shortness of breath, a chronic dry cough, or unexplained fatigue that interferes with daily life. Early evaluation allows doctors to perform lung tests and imaging to confirm the cause.

Seek urgent care if breathing suddenly worsens, lips or fingers turn blue, or chest pain appears. These may signal acute exacerbation, respiratory failure, or another emergency.

Prompt medical attention helps manage symptoms, slow disease progression, and prevent serious complications.

Causes and Risk Factors

Pulmonary fibrosis develops when lung tissue becomes scarred from repeated injury or inflammation. We often see this damage result from environmental exposures, certain medications, autoimmune diseases, or unknown genetic factors that affect how lung cells heal and regenerate.

Environmental and Occupational Exposures

Long-term exposure to harmful particles or fumes can lead to scarring in the lungs. People who work in construction, mining, or manufacturing may breathe in asbestos, silica, coal dust, or beryllium, all of which can damage lung tissue over time.

Inhaling mold spores, bird proteins, or other organic materials can trigger hypersensitivity pneumonitis, a condition where the immune system reacts to inhaled particles and causes chronic inflammation.

Pollutants and toxins in the air, including smoke and industrial chemicals, can also irritate lung tissue. These exposures often occur slowly and silently, making early detection difficult.

Limiting contact with dust and using protective equipment at work can help reduce risk.

Medications and Medical Treatments

Some prescription drugs and medical treatments can cause pulmonary fibrosis as a side effect. Chemotherapy drugs such as bleomycin and cyclophosphamide may injure lung cells while treating cancer.

Other medications linked to lung scarring include amiodarone (used for heart rhythm problems), methotrexate (used for arthritis and autoimmune diseases), and nitrofurantoin (an antibiotic for urinary infections).

Radiation therapy to the chest for conditions like breast or lung cancer can also damage lung tissue, especially when combined with certain chemotherapy drugs.

We always review each patient’s medication history and treatment exposure when evaluating potential causes.

Autoimmune and Connective Tissue Diseases

Autoimmune diseases can cause the immune system to attack healthy lung tissue. Conditions such as rheumatoid arthritis, scleroderma, lupus, polymyositis, and dermatomyositis may lead to inflammation that results in fibrosis.

These diseases are sometimes called connective tissue diseases because they affect the body’s connective structures, including the lungs. The severity of lung involvement varies, but early recognition and treatment of the underlying autoimmune condition can slow progression.

In some cases, sarcoidosis or chronic inflammation from immune activity can also contribute to scarring. Regular monitoring helps us identify changes in lung function before significant damage occurs.

Genetic and Unidentified Factors

When no clear cause is found, the condition is called idiopathic pulmonary fibrosis (IPF). Genetics likely plays a role, as some families show inherited patterns of lung scarring.

Certain genes may affect how the lungs repair after injury, increasing the risk of fibrosis. Aging and smoking are additional factors that make the lungs more vulnerable to damage.

Other possible contributors include chronic lung infections, bacterial inflammation, and gastroesophageal reflux disease (GERD), which can cause stomach acid to reach the lungs and irritate tissue. Even when the exact cause remains unknown, identifying risk factors helps guide prevention and management.

Diagnosis of Pulmonary Fibrosis

We use a combination of medical history, imaging, lung function testing, blood analysis, and sometimes tissue sampling to confirm pulmonary fibrosis. Each step helps us understand how much scarring is present, identify possible causes, and guide treatment decisions.

Initial Assessment and Medical History

We begin by reviewing a patient’s medical and family history. This includes asking about symptoms such as shortness of breath, dry cough, or fatigue.

We also discuss any exposure to dust, chemicals, or gases, since environmental and occupational factors can contribute to lung scarring. A physical exam often reveals “crackles” when listening to the lungs with a stethoscope.

These sounds resemble Velcro being pulled apart and may indicate stiff, scarred lung tissue. We also review medications and any history of autoimmune disease or infections.

Understanding these factors helps us determine whether the fibrosis is idiopathic (without a known cause) or secondary to another condition. This early step narrows down possible causes before moving to imaging and testing.

Imaging and Lung Function Tests

We rely on imaging to visualize lung structure. A chest X-ray can show general patterns of scarring, but it may miss early disease.

A high-resolution CT (HRCT) scan provides a more detailed view, showing the exact location and extent of fibrosis. HRCT scans help distinguish pulmonary fibrosis from other interstitial lung diseases.

To evaluate how well the lungs work, we perform pulmonary function tests (PFTs). These tests measure:

Test Purpose
Forced Vital Capacity (FVC) Measures the total air exhaled after a deep breath
Diffusing Capacity (DLCO) Assesses how well oxygen passes from the lungs into the blood
Spirometry Detects airflow restriction and lung stiffness

These results show how much air the lungs can hold and how efficiently they transfer oxygen. Reduced volumes and oxygen exchange often indicate disease progression.

Blood Tests and Laboratory Analysis

We use blood tests to look for signs of inflammation, infection, or autoimmune activity. These tests help rule out other causes of lung scarring and identify treatable conditions.

Common laboratory evaluations include:

  • Autoimmune panels for diseases like rheumatoid arthritis or scleroderma
  • Liver and kidney function tests to check for systemic involvement
  • Markers of inflammation, such as ESR or CRP

Blood results alone cannot diagnose pulmonary fibrosis. They support findings from imaging and clinical exams.

Tissue Sampling and Biopsy

If imaging and blood work do not confirm the cause, we may recommend a lung biopsy. This allows direct examination of lung tissue under a microscope to identify the pattern of scarring.

There are several ways to obtain tissue:

  • Bronchoscopy with bronchoalveolar lavage (BAL): A thin tube collects cells and fluid from the lungs.
  • Transbronchial biopsy: Small samples are taken through the bronchoscope.
  • Surgical (video-assisted thoracoscopic) biopsy: Used when larger tissue samples are needed.

Biopsy results can distinguish among more than 200 types of pulmonary fibrosis. This information helps us select appropriate treatment options and predict disease behavior.

Treatment Options and Disease Management

We focus on slowing lung scarring and easing breathing. Treatment often combines medication, oxygen support, and structured rehabilitation. In severe cases, surgery or a transplant may be considered.

Medications and Antifibrotic Therapies

We use antifibrotic medications to slow the progression of pulmonary fibrosis. The two main drugs approved by the U.S. Food and Drug Administration are pirfenidone (Esbriet) and nintedanib (Ofev).

These medicines can help reduce the rate of lung function decline. Pirfenidone may lessen inflammation and fibrosis in lung tissue.

Nintedanib works by blocking pathways that lead to scarring. Both can cause side effects such as nausea, diarrhea, or sensitivity to sunlight. Regular monitoring of liver function is important.

In some cases, corticosteroids like prednisone or immune-suppressing drugs such as azathioprine, colchicine, or cyclophosphamide may be used when inflammation plays a role. These medicines are not suitable for everyone, so we adjust treatment based on the cause and severity of the disease.

Researchers continue to study new antifibrotic agents through clinical trials. This offers patients access to emerging therapies when standard options are limited.

Oxygen Therapy and Supplemental Oxygen

Oxygen therapy helps maintain healthy oxygen levels in the blood when lung scarring reduces oxygen exchange. Supplemental oxygen does not stop fibrosis, but it can make breathing easier and reduce fatigue.

We may recommend oxygen use during sleep, exercise, or throughout the day, depending on oxygen saturation levels. Portable oxygen concentrators and small tanks allow mobility and independence.

Proper oxygen use can also help relieve strain on the heart and improve mental alertness. Our team regularly checks oxygen needs using pulse oximetry or walking tests.

Pulmonary Rehabilitation and Breathing Exercises

Pulmonary rehabilitation combines exercise, education, and emotional support to help people manage symptoms and stay active. Programs often include:

Focus Area Purpose
Exercise training Improve endurance and muscle strength
Breathing techniques Increase oxygen use efficiency
Nutritional advice Support a healthy weight and energy
Counseling Reduce anxiety and depression

We teach breathing methods such as pursed-lip breathing and diaphragmatic breathing to improve air movement. Regular participation can lessen shortness of breath.

Lung Transplant and Advanced Interventions

A lung transplant may be considered when other treatments no longer control symptoms or oxygen levels. This procedure can extend life expectancy and improve daily function, but it carries risks such as infection and organ rejection.

After a transplant, lifelong use of immunosuppressant medicines is required. We carefully evaluate each candidate’s overall health, age, and support system before recommending surgery.

For those not eligible for transplant, advanced care options may include mechanical ventilation during severe flare-ups or enrollment in clinical trials testing new antifibrotic or gene-based treatments.

Living With Pulmonary Fibrosis

Managing pulmonary fibrosis means balancing medical care with daily habits that protect our lungs and maintain energy. We focus on staying active, preventing infections, and finding emotional and social support.

Lifestyle Adjustments and Self-Care

We can support our lung health through small, steady changes. Regular exercise, such as walking or light stretching, helps us stay strong and improves breathing efficiency.

Our lung specialist may recommend a pulmonary rehabilitation program to teach safe breathing techniques and improve endurance.

A balanced diet rich in fruits, vegetables, lean protein, and whole grains gives us energy and supports our immune system. Staying hydrated also helps keep mucus thin, making it easier to clear the airways.

We should avoid smoking, secondhand smoke, and air pollutants. Using air filters at home and checking local air quality before going outside can reduce irritation.

Rest is also important. Short naps and pacing our activities help us manage fatigue.

Preventing Complications and Infections

Because pulmonary fibrosis weakens the lungs, preventing infection is a key part of care. We should get a yearly flu shot and stay up to date with pneumonia and COVID-19 vaccines to lower our risk of serious illness.

Good handwashing and avoiding close contact with people who are sick help reduce exposure to viruses.

If we notice symptoms such as increased coughing, fever, or changes in mucus, we should contact our lung specialist right away. Prompt treatment can prevent a minor lung infection from becoming severe.

Using a humidifier can ease breathing, but we must clean it often to avoid mold growth. Our doctor may also recommend oxygen therapy if our oxygen levels drop during activity or sleep.

Long-Term Outlook and Support

Living with pulmonary fibrosis can be emotionally and physically challenging. Joining a support group connects us with others who understand what we are going through.

Support groups can help us share coping strategies.

We should schedule regular checkups with our lung specialist to track disease progression. Early attention to changes in symptoms helps us maintain stability.

Planning ahead—such as discussing care goals, treatment options, and daily routines—gives us more control. This can reduce uncertainty.

Conclusion: Early Detection and Expert Management Make All the Difference

Pulmonary fibrosis is a complex condition that affects how the lungs function and how well the body receives oxygen. Understanding its symptoms, causes, and treatment options can empower patients to take a proactive approach to their health. Because the disease can progress at different rates—and sometimes without obvious early signs—ongoing monitoring, lifestyle adjustments, and timely intervention are essential. With the right care plan, patients can slow disease progression, maintain their independence, and improve their overall quality of life. Partnering with experienced pulmonologists is one of the most effective ways to ensure that changes in lung function are caught early and managed appropriately.

Choose specialized care designed to support your long-term lung health.

At Gwinnett Pulmonary & Sleep, our board-certified pulmonologists offer comprehensive evaluation, advanced diagnostic testing, and personalized treatment for pulmonary fibrosis. Whether you’re experiencing symptoms or seeking expert guidance after diagnosis, our team is here to help you breathe easier and live better.

Book your appointment today at gwinnettlung.com or call 770-995-0630 to schedule your visit.

Plugin powered by Kapsule Corp

Gwinnett Pulmonary & Sleep
GET IN TOUCH